Silicon Laboratories, Inc. (NASDAQ:SLAB) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eight brokerages that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $126.50.

A number of research firms recently commented on SLAB. Wall Street Zen raised Silicon Laboratories from a "sell" rating to a "hold" rating in a research note on Wednesday, May 14th. Barclays dropped their price target on Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 22nd. Stifel Nicolaus dropped their price target on Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating for the company in a research note on Thursday, April 17th. Benchmark reaffirmed a "buy" rating and issued a $160.00 price target on shares of Silicon Laboratories in a research note on Tuesday, May 27th. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $150.00 price target on shares of Silicon Laboratories in a research note on Wednesday, May 14th.

Insiders Place Their Bets

In other news, SVP Robert J. Conrad sold 1,172 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $130.00, for a total value of $152,360.00. Following the completion of the transaction, the senior vice president now owns 15,972 shares of the company's stock, valued at $2,076,360. This represents a 6.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Christy Wyatt sold 546 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $104.45, for a total value of $57,029.70. Following the completion of the transaction, the director now directly owns 8,492 shares of the company's stock, valued at $886,989.40. This represents a 6.04% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 11,626 shares of company stock valued at $1,509,319. 1.60% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Strs Ohio acquired a new position in shares of Silicon Laboratories in the first quarter valued at approximately $720,000. Foresight Group Ltd Liability Partnership bought a new stake in Silicon Laboratories in the first quarter valued at approximately $13,560,000. Intech Investment Management LLC boosted its holdings in Silicon Laboratories by 12.7% in the first quarter. Intech Investment Management LLC now owns 20,225 shares of the semiconductor company's stock valued at $2,277,000 after acquiring an additional 2,273 shares during the last quarter. Jane Street Group LLC boosted its holdings in Silicon Laboratories by 329.2% in the first quarter. Jane Street Group LLC now owns 75,397 shares of the semiconductor company's stock valued at $8,487,000 after acquiring an additional 57,829 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Silicon Laboratories by 1.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 97,156 shares of the semiconductor company's stock valued at $10,937,000 after acquiring an additional 1,679 shares during the last quarter.

Silicon Laboratories Stock Performance

SLAB traded down $0.79 during trading on Friday, reaching $141.02. 495,995 shares of the stock were exchanged, compared to its average volume of 342,263. The stock has a market cap of $4.59 billion, a P/E ratio of -27.60 and a beta of 1.42. Silicon Laboratories has a twelve month low of $82.82 and a twelve month high of $160.00. The stock's 50 day moving average price is $116.44 and its two-hundred day moving average price is $124.63.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The semiconductor company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.01. The firm had revenue of $177.71 million for the quarter, compared to the consensus estimate of $177.48 million. Silicon Laboratories had a negative net margin of 25.16% and a negative return on equity of 8.80%. The company's quarterly revenue was up 67.0% on a year-over-year basis. During the same period in the previous year, the company earned ($0.92) earnings per share. Equities research analysts predict that Silicon Laboratories will post -0.97 earnings per share for the current fiscal year.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.